Pantoprazole Sodium Tablet, Delayed Release
Product Images NDC 68788-8644

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Pantoprazole Sodium (NDC 68788-8644). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Camberlogo1 (Camberlogo1)

FDA Label Image

Camberlogo2 (Camberlogo2)

FDA Label Image

Pantoprazole Sodium Delayed-release Tablets 40mg (Pantoprazole40mg)

Pantoprazole Sodium Delayed-Release Tablets 40 mg label for oral administration. The label shows the product is a delayed-release tablet, manufactured by Hetero Labs Limited and labeled by Preferred Pharmaceuticals Inc. It includes space for lot, batch, and expiration details, with storage instructions to keep at controlled room temperature. The label also features dosing instructions in English and Spanish, a barcode, and federal caution about drug transfer restrictions.*

FDA Label Image

Structure.jpg (Structure)

Chemical structure of pantoprazole, showing the molecular arrangement including sodium and water of hydration (1.5 H2O). This structural diagram highlights the fluorinated benzene ring, pyridine ring with methoxy group, and sulfoxide functional group characteristic of pantoprazole.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.